Brand profile · Biotechnology Research

EpiAxis Therapeutics

Canberra, ACT-based EpiAxis Therapeutics operates in Biotechnology Research. It is privately held, and its site is epiaxistherapeutics.com. It holds one address on record, all in Australia. Headcount on record is 7. One Australian registration (ABN) is a confirmed match. Its latest round on record is Series unknown, with no amount recorded. It is listed alongside eight similar brands, mostly in Pharmaceutical Manufacturing.

epiaxistherapeutics.com LinkedIn

Profile live Privately Held 1 entity ABN 1 office country 2 funding rounds
Registry verified · ABR
Counted staff
7
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
2
Series unknown · Apr 2021
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • EPIAXIS THERAPEUTICS PTY LTD

    ABN13609854980

    ACTHigh confidenceMatched on exact nameABR

Legal entities

EpiAxis Therapeutics: 1 registry entityEpiAxis Therapeutics is linked to 1 registry entity: EPIAXIS THERAPEUTICS PTY LTD (ABN 13609854980, candidate).EpiAxis TherapeuticsEPIAXIS THERAPEUTICSPTY LTDABN 13609854980Candidate · High confidence
Show as table
EPIAXIS THERAPEUTICS PTY LTDABN 13609854980
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Leading epigenetic company with a focus on the prevention of metastatic disease

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUBruce; Canberra, ACT 2617Primary

Grid intelligence Members

Funding

Last round · 5 April 2021Amount not recordedSeries unknown · investor: Artesian VC
Rounds2
Round typeSeries unknown · venture round
Amount (USD)not recorded
Stage ranknot recorded
Investors named1
Since last round4 yr 9 mo

Funding

2 funding roundsFunding timeline. Latest round 5 Apr 2021: Series unknown, amount not disclosed.20212026Series unknownamount not disclosed2 rounds
Show as table
Rounds2
Axis2021 to 2026
Series unknown · 5 Apr 2021not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under EpiAxis Therapeutics?

One Australian Capital Territory entity on the ABR: EPIAXIS THERAPEUTICS PTY LTD (ABN 13 609 854 980), high confidence.

How many people work at EpiAxis Therapeutics?

7 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does EpiAxis Therapeutics have offices?

One address on record, Australia only. Primary: Bruce, Canberra, ACT 2617.

Has EpiAxis Therapeutics raised funding?

Two rounds. Latest 5 April 2021: Series unknown, investor Artesian VC, no amount recorded.

Which companies are listed alongside EpiAxis Therapeutics?

3 profiles list EpiAxis Therapeutics as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Elizabeth Broderick & Co and VC Women Down Under list it back.

What is EpiAxis Therapeutics's website?

epiaxistherapeutics.com